89581-70-4

Basic information

• Product Name: 6-Chloro-2,4-dihydroxy-5-methyl-3-nitropyridine
• Synonyms: 6-Chloro-2,4-dihydroxy-5-methyl-3-nitropyridine;6-Chloro-4-hydroxy-5-methyl-3-nitro-1H-pyridin-2-one
• CAS NO: 89581-70-4
• Molecular Formula: C6H5ClN2O4
• Molecular Weight: 204.5679
• Mol File: 89581-70-4.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-Chloro-2,4-dihydroxy-5-methyl-3-nitropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Chloro-2,4-dihydroxy-5-methyl-3-nitropyridine(89581-70-4)
• EPA Substance Registry System: 6-Chloro-2,4-dihydroxy-5-methyl-3-nitropyridine(89581-70-4)

Safety Data

• Hazardous Substances Data: 89581-70-4(Hazardous Substances Data)

Upstream product

• 95306-65-3 6-Chloro-4-hydroxy-5-methyl-2-oxo-1,2-dihydropyridine hydrochloride 
• 89379-84-0 6-Chloro-2,4-dihydroxy-5-methyl-pyridine 

Relevant articles and documents

NOVEL PHARMACEUTICALS

The present invention relates to immune response modifiers of formula (I), which act selectively through agonism, of Toll-Like Receptors (TLRs), uses thereof, processes for the preparation thereof, intermediates used in the preparation thereof and compositions containing said inhibitors. These inhibitors have utility in a variety of therapeutic areas including the treatment of infectious disease such as Hepatitis (e.g. HCV, HBV), genetically related viral infection and cancer.

Ether substituted imidazopyridines

Imidazopyridine compounds that contain an ether or thioether functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Amide substituted imidazopyridines

Imidazopyridine compounds that contain amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.